RxDoctor Payments Data

David Poetker, MD

Otolaryngology · Milwaukee, WINPI 1265447783

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Neurent Medical Limited accounts for 90.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $11,303 and has fallen 97.0% since, to $335 in 2025. Among otolaryngology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,682in general payments, 2019–2025

Across 28 payments — averaging $452.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurent Medical Limited$12K
  • Medtronic$307
  • Acclarent, Inc$240
  • Aerin Medical Inc.$200
  • Integra Lifesciences Corporation$173
  • Intersect ENT, Inc.$143
  • plus $109 from 2 others
$71,245in research payments, 2019–2025

Across 14 payments — averaging $5088.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$35K
  • Optinose US, Inc.$17K
  • GSK$15K
  • Roche Products Limited$5K

What the payments were for

  • Consulting fees$5,25041%
  • Travel & lodging$5,21741%
  • Food & beverage$2,21517%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,682 in reported general payments places this provider in the 95th percentile of 168 otolaryngology providers in Wisconsin.

See all otolaryngology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$41,374
Medicare patients
229
Services billed
499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab41$151,759
XhanceFluticasone Propionate20$13,022
Azelastine Hcl212$7,103
Ipratropium Bromide179$6,567
Fluticasone Propionate246$4,840
Prednisolone Acetate22$2,168
Doxycycline Monohydrate15$1,343
Mupirocin74$785
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$518
Doxycycline Hyclate36$506
Cefdinir17$327
Methylprednisolone14$82
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$74
Prednisone19$54
Amoxicillin11$51

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →